IGF-I R

IGF-I R Overview

English NameInsulin-like growth factor I receptorApproved Drugs7
Drugs in Clinical Trials25Target SynonymIGF-I receptor,IGF1R,Insulin Like Growth Factor 1 Receptor,Insulin-Like Growth Factor 1 Receptor,Insulin-Like Growth Factor I Receptor,Soluble IGF1R Variant 1,Soluble IGF1R Variant 2,CD221 Antigen,CD221,IGFIR,JTK13,IGFR,Receptor, IGF Type 1,MGC18216
Highest Development StageApproved
English NameInsulin-like growth factor I receptor
Target SynonymIGF-I receptor,IGF1R,Insulin Like Growth Factor 1 Receptor,Insulin-Like Growth Factor 1 Receptor,Insulin-Like Growth Factor I Receptor,Soluble IGF1R Variant 1,Soluble IGF1R Variant 2,CD221 Antigen,CD221,IGFIR,JTK13,IGFR,Receptor, IGF Type 1,MGC18216
Approved Drugs7
Drugs in Clinical Trials25
Highest Development StageApproved

IGF-I R Product List

  • Product Category

    Cell (2)Protein (2)

  • Product Status

    Launched (4)

  • Species

    Human (2)Cynomolgus (2)

  • Tag

    - (2)His Tag (1)His Tag & Avi Tag (1)

  • Conjugate

    - (2)Unconjugated (1)Biotin-labeled (1)

IGF-I R Background

The Insulin-like Growth Factor 1 Receptor (IGF1R) is also known as CD221 and JTK13, and is a transmembrane receptor that is activated by IGF-1 and by the related growth factor IGF-2. It belongs to the large class of tyrosine kinase receptors. This receptor mediates the effects of IGF-1, which is a polypeptide hormone similar in molecular structure to insulin. IGF1R is made up of two α subunits and two β subunits. Both the α and β subunits are synthesized from a single mRNA precursor. The precursor is then glycosylated, proteolytically cleaved, and crosslinked by disulfide bonds to form a functional transmembrane αβ chain. The α chains are located extracellularly, while the β subunits span the membrane and are responsible for intracellular signal transduction upon ligand stimulation. IGF1R has a binding site for ATP, which is used to provide the phosphates for autophosphorylation. There is 60% sequence homology between IGF1R and the insulin receptor. In response to ligand binding, the α chains induce the tyrosine autophosphorylation of the β chains. This event triggers a cascade of intracellular signaling that, while somewhat cell type specific, often promotes cell survival and cell proliferation.

IGF-I R Synonyms

IGF1R,IGFR,JTK13,CD221,MGC142170,MGC142172,MGC18216

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
ElegrobartVRDN-003Phase 3 ClinicalViridian Therapeutics IncGraves Ophthalmopathy
Details
ZL-1109ZL-1109; ZL1109Phase 3 ClinicalZai Lab (Shanghai) Co LtdGraves Ophthalmopathy
Details
MHB-018AMHB 018A; MHB-018APhase 3 ClinicalMinghui Pharmaceutical (Hangzhou) Co LtdGraves Ophthalmopathy
Details
GanitumabAMG-479Phase 3 ClinicalAmgen IncBone metastases; Breast Neoplasms; Carcinoid Tumor; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Intestinal Neoplasms; Lung Neoplasms; Lymphoma; Neoplasm Metastasis; Neoplasms; Neuroectodermal Tumors, Primitive; Neuroectodermal Tumors, Primitive, Peripheral; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Rhabdomyosarcoma; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; Sarcoma; Sarcoma, Ewing; Small Cell Lung Carcinoma; Solid tumours
Details
LinsitinibOSI-906; ASP-7487; OSI-906AAPhase 3 ClinicalAstellas Pharma Inc, National Cancer InstituteAdrenocortical Carcinoma; Breast Neoplasms; Carcinoma, Basosquamous; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carney Complex; Chondrosarcoma; Colorectal Neoplasms; Endocrine System Diseases; Exophthalmos; Eye Diseases; Gastrointestinal Stromal Tumors; Graves Ophthalmopathy; Hashimoto Disease; Head and Neck Neoplasms; Hormone-Resistant Prostate Neoplasms; Lip Neoplasms; Liver Neoplasms; Mouth Neoplasms; Multiple Myeloma; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Paraganglioma; Prostatic Neoplasms; Sarcoma, Ewing; Skin Neoplasms; Small Cell Lung Carcinoma; Solid tumours; Thyroid Diseases
Details
225 Actinium-FPI-1434225Ac-FPI-1434; [225Ac]-FPI-1434; FPX-01; FPI-1434Phase 2 ClinicalCentre For Probe Development And CommercializationAdrenocortical Carcinoma; Breast Neoplasms; Endometrial Neoplasms; Neoplasms; Ovarian Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Uterine Cervical Neoplasms; Uveal melanoma
Details
CT-102CT-102Phase 2 ClinicalHangzhou Tianlong Pharmaceutical Co Ltd, Institute Of Radiation And Radiation Medicine, Chinese Academy Of Military Medical SciencesCarcinoma, Hepatocellular; Liver Neoplasms
Details
Mecasermin RinfabaterhIGF-I/rhIGFBP-3; TAK-607; OHB-607; IGF-I/IGFBP-3; SHP-607; HGT-ROP-001Phase 2 ClinicalInsmedBronchopulmonary Dysplasia; Cerebral Intraventricular Hemorrhage; Failure to Thrive; Laron Syndrome; Lung Diseases; Myotonic Dystrophy; Noonan Syndrome; Retinopathy of Prematurity
Details
Insulin growth factor receptor type 1 antisense therapy (Imvax)IGV-001Phase 2 ClinicalThomas Jefferson UniversityGlioblastoma
Details
AMG-732HZN-280; AMG-732; AMG732; AMG 732Phase 2 ClinicalAmgen IncGraves Ophthalmopathy
Details
PHP-1003PHP-1003; PHP1003Phase 2 ClinicalSuzhou Pulekang Pharmaceutical Technology Co LtdGraves Ophthalmopathy
Details
CixutumumabA-12; IMC-A12; LY-3012217; NSC-742460Phase 2 ClinicalEli Lilly And CompanyAdenocarcinoma; Adenocarcinoma of Lung; Adenocarcinoma, Bronchiolo-Alveolar; Adrenocortical Carcinoma; Brain Stem Neoplasms; Breast Neoplasms; Breast Neoplasms, Male; Carcinoma; Carcinoma, Hepatocellular; Carcinoma, Merkel Cell; Carcinoma, Neuroendocrine; Carcinoma, Non-Small-Cell Lung; Chondrosarcoma, Extraskeletal Myxoid; Colonic Neoplasms; Colorectal Neoplasms; Dermatofibrosarcoma; Desmoplastic Small Round Cell Tumor; Esophageal adenocarcinoma; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fibrosarcoma; Gastrinoma; Gastroenteropancreatic neuroendocrine tumor; Glioma; Gliosarcoma; Glucagonoma; Head and Neck Neoplasms; Heart Diseases; Hemangiopericytoma; Hemangiosarcoma; Hepatoblastoma; Hormone-Resistant Prostate Neoplasms; Insulinoma; Kidney Neoplasms; Leiomyosarcoma; Leukemia, Mast-Cell; Liposarcoma; Liver Neoplasms; Lung Neoplasms; Lymphoma, Mantle-Cell; Medullary thyroid cancer (MTC); Melanoma; Mesenchymoma; Mesothelioma; Metastatic breast cancer; Neoplasms; Neuroblastoma; Neuroectodermal Tum
Details
PicropodophyllinAXL-1717; NSC-36407; PPPPhase 2 ClinicalAxelar AbAstrocytoma; Carcinoma, Non-Small-Cell Lung; Ependymoma; Glioblastoma; Gliosarcoma; Oligodendroglioma; Papillomavirus Infections
Details
NNC0268-0965NNC0268-0965Phase 1 ClinicalNovo Nordisk A/SDiabetes Mellitus, Type 1; Diabetes Mellitus, Type 2
Details
IGF-1 receptor oligodeoxynucleotide-based immunotherapy (Thomas Jefferson University)Phase 1 ClinicalSidney Kimmel Cancer CenterGlioma
Details
Insulin-Like Growth Factor 1 (Wright State Physicians)Phase 1 ClinicalWright State PhysiciansHealthy Aging; Nasolabial fold wrinkles; Sunburn
Details
SAR-446159SAR-446159; ABL-301Phase 1 ClinicalAbl Bio IncParkinson Disease
Details
VRDN-002VRDN-002Phase 1 ClinicalViridian Therapeutics IncGraves Ophthalmopathy
Details
LX-101 (Lirum Therapeutics)765IGF-MTX; IGF/MTX; LX-101Phase 1 ClinicalIgf Oncology LlcAnemia, Refractory, with Excess of Blasts; Brain Neoplasms; Breast Neoplasms; Gastrointestinal Neoplasms; Genital Neoplasms, Female; Graves Ophthalmopathy; Head and Neck Neoplasms; Leukemia, Myelomonocytic, Chronic; Melanoma; Myelodysplastic Syndromes; Neoplasms; Urogenital Neoplasms
Details
ZB-011ZB-011; ZB011Phase 1 ClinicalViridian Therapeutics IncGraves Ophthalmopathy
Details
Teprotumumab biosimilar(Boxiao Bio-pharma)Phase 1 ClinicalZhejiang Boxiao Bio-pharmaceutical Co LtdGraves Ophthalmopathy
Details
124I-CPD-1023-figitumumabCPD-1028-[124I]; CPD-1028-[125I]; 124I-CPD-1028; FPX-1028; 125I-CPD-1028Phase 1 ClinicalFusion PharmaNeoplasms
Details
ALTSuLINClinicalALTuCELL IncDiabetes Mellitus, Type 1; Laron Syndrome
Details
68Ga-NODAGA-ZIGF-1R:4:40ClinicalHarbin Medical UniversityNeoplasms
Details
LonigutamabVB-421Pierre Fabre GroupGraves Ophthalmopathy
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyEarliest Brand NameEarliest Approval CountryEarliest IndicationEarliest Approval CompanyEarliest Approval DateIndicationClinical Trial
Mecasermin (Astellas/OrphanPacific)ApprovedAstellas Pharma IncSomazonJapanGrowth hormone deficiency; Diabetes Mellitus, Lipoatrophic; Dwarfismnull1994-10-05Diabetes Mellitus, Lipoatrophic; Dwarfism; Growth hormone deficiency; Heart Failure; HIV-Associated Lipodystrophy Syndrome; Multiple Sclerosis; Myocardial Infarction
Details
Mecasermin (Ipsen)FK-780; IGF-1; MKN-031; rhIGF-I (Ipsen)ApprovedGenentech IncIncrelexUnited StatesFailure to ThriveIpsen Inc2005-08-30Autism Spectrum Disorder; Failure to Thrive; Growth Disorders; Laron Syndrome; Phelan-McDermid syndrome; X-Linked Combined Immunodeficiency Diseases
Details
BrigatinibAP-26113ApprovedAriad Pharmaceuticals IncAlunbrig, ALUNBRIGUnited StatesCarcinoma, Non-Small-Cell LungTakeda Pharmaceuticals USA Inc2017-04-28Brain metastases; Carcinoma; Carcinoma, Non-Small-Cell Lung; Ependymoma; Granuloma, Plasma Cell; Lung Neoplasms; Lymphoma, Large-Cell, Anaplastic; Meningioma; Myofibroma; Neoplasms; Neurilemmoma; Neurofibromatosis 2; Neuroma, Acoustic; Sarcoma, Kaposi; Solid tumours
Details
IGF-1 (Biogen/Pharmacia & Upjohn)ApprovedBiogen Inc, Pharmacia & UpjohnIgefSwedenDwarfismnull1994-01-01Dwarfism
Details
CeritinibLDK-378; NVP-LDK378; NVP-LDK378-NXApprovedNovartis Pharma Ag赞可达, ZykadiaEUCarcinoma, Non-Small-Cell LungNovartis Europharm Ltd2014-04-29Adenocarcinoma; Brain metastases; Carcinoma, Non-Small-Cell Lung; Cholangiocarcinoma; Colorectal Neoplasms; Esophageal adenocarcinoma; Glioblastoma; Granuloma, Plasma Cell; Hematologic Neoplasms; Hepatic Insufficiency; Liver Dysfunction; Lymphoma, Large-Cell, Anaplastic; Melanoma; Neoplasms; Pancreatic Neoplasms; Stomach Neoplasms; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms
Details
Teprotumumab N01IBI-311Approved信必敏, SYCUMEMainland ChinaGraves OphthalmopathyInnovent Biologics(Suzhou) Co Ltd2025-03-11Graves Ophthalmopathy
Details
TeprotumumabRO-4858696; HZN-001; RV-001(River Vision); R-1507; RG-1507ApprovedF. Hoffmann-La Roche Ltd, Genmab A/STepezzaUnited StatesGraves OphthalmopathyHorizon Therapeutics Ireland2020-01-21Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Diabetic macular oedema; Graves Ophthalmopathy; Neoplasms; Sarcoma; Scleroderma, Diffuse
Details
  • Overview
  • Product List
  • Marketed Drug Information
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland